The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The Blood–Brain Barrier (BBB) Score
Abstract
The blood-brain barrier (BBB) protects the brain from the toxic side effects of drugs and exogenous molecules. However, it is crucial that medications developed for neurological disorders cross into the brain in therapeutic concentrations. Understanding the BBB interaction with drug molecules based on physicochemical property space can guide effective and efficient drug design. An algorithm, designated "BBB Score", composed of stepwise and polynomial piecewise functions, is herein proposed for predicting BBB penetration based on five physicochemical descriptors: number of aromatic rings, heavy atoms, MWHBN (a descriptor comprising molecular weight, hydrogen bond donor, and hydrogen bond acceptors), topological polar surface area, and pKa. On the basis of statistical analyses of our results, the BBB Score outperformed (AUC = 0.86) currently employed MPO approaches (MPO, AUC = 0.61; MPO_V2, AUC = 0.67). Initial evaluation of physicochemical property space using the BBB Score is a valuable addition to currently available drug design algorithms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ranković, Z. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01469 · Cited by 102
RetractedAn introduction to ROC analysis
Fawcett, T. (2006) · Pattern Recognition Letters · doi:10.1016/j.patrec.2005.10.010 · Cited by 21,879
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
CHARMM: A program for macromolecular energy, minimization, and dynamics calculations
Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., & Karplus, M. (1983) · Journal of Computational Chemistry · doi:10.1002/jcc.540040211 · Cited by 14,944
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
The use of the area under the ROC curve in the evaluation of machine learning algorithms
Bradley, A. P. (1997) · Pattern Recognition · doi:10.1016/s0031-3203(96)00142-2 · Cited by 7,217
The relationship between Precision-Recall and ROC curves
Davis, J., & Goadrich, M. (2006) · Proceedings of the 23rd international conference on Machine learning - ICML '06 · doi:10.1145/1143844.1143874 · Cited by 6,559
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Waring, M. J., Arrowsmith, J., Leach, A. R., Leeson, P. D., Mandrell, S., Owen, R. M., Pairaudeau, G., Pennie, W. D., Pickett, S. D., Wang, J., et al. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4609 · Cited by 1,450
Wager, T. T., Hou, X., Verhoest, P. R., & Villalobos, A. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100008c · Cited by 1,063
Ritchie, T. J., & Macdonald, S. J. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.014 · Cited by 901
Statistics review 13: receiver operating characteristic curves.
Bewick, V., Cheek, L., & Ball, J. (2004) · Critical Care · doi:10.1186/cc3000 · Cited by 818
Kelder, J., Grootenhuis, P. D. J., Bayada, D. M., Delbressine, L. P. C., & Ploemen, J.-P. (1999) · Pharmaceutical Research · doi:10.1023/a:1015040217741 · Cited by 813
Structure−Brain Exposure Relationships
Hitchcock, S. A., & Pennington, L. D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060642i · Cited by 698
Central nervous system multiparameter optimization desirability: Application in drug discovery
Wager, T. T., Hou, X., Verhoest, P. R., & Villalobos, A. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00029 · Cited by 653
Triballeau, N., Acher, F., Brabet, I., Pin, J.-P., & Bertrand, H.-O. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049092j · Cited by 631
van de Waterbeemd, H., Camenisch, G., Folkers, G., Chretien, J. R., & Raevsky, O. A. (1998) · Journal of Drug Targeting · doi:10.3109/10611869808997889 · Cited by 587
Wager, T. T., Chandrasekaran, R. Y., Hou, X., Troutman, M. D., Verhoest, P. R., Villalobos, A., & Will, Y. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100007x · Cited by 477
Ghose, A. K., Herbertz, T., Hudkins, R. L., Dorsey, B. D., & Mallamo, J. P. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200100h · Cited by 447
Time-Related Differences in the Physical Property Profiles of Oral Drugs
Leeson, P. D., & Davis, A. M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049717d · Cited by 326
Computational approaches to the prediction of the blood–brain distribution
Norinder, U., & Haeberlein, M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00005-4 · Cited by 305
Probabilistic record linkage and a method to calculate the positive predictive value
Blakely, T., & Salmond, C. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.6.1246 · Cited by 221
Zhang, D. D., Zhou, X., Freeman, D. H., & Freeman, J. L. (2002) · Statistics in Medicine · doi:10.1002/sim.1011 · Cited by 137
Comparison of lipid-mediated blood-brain-barrier penetrability in neonates and adults
Cornford, E. M., Braun, L. D., Oldendorf, W. H., & Hill, M. A. (1982) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1982.243.3.c161 · Cited by 125
Probabilistic Approach to Generating MPOs and Its Application as a Scoring Function for CNS Drugs
Günaydin, H. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00390 · Cited by 61
Ghose, A. K., Ott, G. R., & Hudkins, R. L. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00273 · Cited by 43
Dolgikh, E., Watson, I. A., Desai, P. V., Sawada, G. A., Morton, S., Jones, T. M., & Raub, T. J. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00229 · Cited by 33
Securing the future of drug discovery for central nervous system disorders
on behalf of the 2013 CINP Summit Group (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4489 · Cited by 14
Irradiation of the head by60Co opens the blood-brain barrier for drugs in rats
Bezek, Š., Trnovec, T., Ščasnár, V., Ďurišová, M., Kukan, M., Kállay, Z., Laginová, V., & Svoboda, V. H. J. (1990) · Cellular and Molecular Life Sciences · doi:10.1007/bf01940660 · Cited by 12
A Mathematical Model for Prediction of Drug Molecule Diffusion Across the Blood-Brain Barrier
Burns, J., & Weaver, D. F. (2004) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100003759 · Cited by 12
Self-citation
Cited by
Drug discovery with explainable artificial intelligence
Jiménez-Luna, J., Grisoni, F., & Schneider, G. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-00236-4 · Cited by 1,063
Challenges and Opportunities in Cancer Drug Resistance
Ward, R. A., Fawell, S., Floc’h, N., Flemington, V., McKerrecher, D., & Smith, P. D. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00383 · Cited by 445
A Perspective on Multi-target Drugs for Alzheimer’s Disease
Benek, O., Korabecny, J., & Soukup, O. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.04.008 · Cited by 260
Xiong, B., Wang, Y., Chen, Y., Xing, S., Liao, Q., Chen, Y., Li, Q., Li, W., & Sun, H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00910 · Cited by 232
Essential Medicinal Chemistry of Essential Medicines
Serafini, M., Cargnin, S., Massarotti, A., Pirali, T., & Genazzani, A. A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00415 · Cited by 46
Metadata
- Authors
- Gupta, M., Lee, H. J., Barden, C. J., & Weaver, D. F.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-10-11
- Volume
- 62
- Issue
- 21
- Pages
- 9824-9836
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2979759717
- Cited by
- 332
- References
- 30
- FWCI
- 17.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.